Cross Contamination Control - Live Online Training

27/28 May 2025

Course No. 21607

header-image

Speakers

Robert G. Schwarz

Robert G. Schwarz

GXP-TrainCon

Dr Markus Keller

Dr Markus Keller

Fraunhofer Institute for Manufacturing Engineering and Automation (IPA)

Dr Harald Stahl

Dr Harald Stahl

GEA

Nikolaus Ferstl

Nikolaus Ferstl

Facility Engineering Services

All times mentioned are CEST.

Objectives

This GMP training aims at unveiling possible risks of cross contamination during the production process of Pharmaceutical products and APIs. This is especially important for patients’ safety, product quality and to be in compliance with chapters 3 and 5 of the EU GMP regulation as well as the new EU GMP Annex 1. The prevention of cross contamination is part of the contamination control strategy and has to be documented accordingly taking into consideration QRM principles according ICH-Q9.
 
You will learn
  • how to detect possible risks
  • how to avoid cross contamination
  • how to prove the avoidance of cross contamination
  • how to document a regulatory compliant strategy

Background

Cross Contamination is one of the highest risks for patients using pharmaceutical products. Not only the presence of small amounts of antibiotics or other highly potent compounds in medicinal products can cause severe damage, but also carryover of one product into another pharmaceutical product is of high Risk to the patient. According to the Medicines & Healthcare Products Regulatory Agency in the United Kingdom for example, Product contamination is the second to third highest reason for recalls in the UK in recent years.
 
The EU commission already reacted on that in 2015 by updating the chapters 3 (premises & equipment) and 5 (production) with the focus on minimizing the risk of cross contamination. Already three years before a new EMA Guide on setting health-based exposure limits was published. This new guide has massive Impact on the dedication of facilities and also on the calculation of Limits for cleaning validation. Limits for the maximum carryover now have to be calculated by considering the toxicological/pharmacological properties of each single product, answering the question: how much cross contamination is allowed. The latest document addressing cross contamination is the revised EU GMP Annex 1. It contains several paragraphs dealing with cross contamination and contamination in general which includes a risk-based Contamination Control Strategy (CCS) aligned with Quality Risk Management principles according to ICH-Q9.
 
Reasons for cross contamination can be manifold and caused by technical as well as organisational deficiencies. Insufficient cleaning of equipment, poor facility design or inappropriate design of the HVAC system may be reasons as well as contamination via personnel or primary packing material. But also, the design of the production process itself can be the cause for cross contamination, for example due to open product handling during transfer or sampling operations in shared plants without adequate measures.
 
It is therefore extremely important to mitigate the risk of cross contamination, starting already at the design phase of processes and equipment. In addition, it is essential to understand how contamination risks can be detected. Some measures include quality oversight walks in production Areas or reviewing the documents (SOPs, technical drawings, etc.) already during process development, design qualification and additionally on a regular basis which has to be predefined.
This mitigation of cross contamination risks should be included and regularly reviewed – and updated if required – as part of the contamination control strategy (CCS) which has to be documented accordingly.

Target Group

This training is aimed at Production, QA and engineering Departments of pharmaceutical companies to maintain product quality and patient safety in a regulatory compliant and agile production life cycle. Suppliers for the pharmaceutical industry are also addressed in order to better understand the requirements of their customers.

Date & Technical Requirements

Date
Tuesday, 27 May 2025, 09.00 to approx. 17.00 h
Wednesday, 28 May 2025, 09.00 to approx. 15.00 h
All times mentioned are CEST.
 
Technical Requirements
We use Webex for our live online training courses and webinars. At www.gmp-compliance.org/training/online-training-technical-information you will find all the Information you need to participate in our events and you can check if your system meets the necessary requirements to participate. If the installation of browser extensions is not possible due to your rights in the IT system, please contact your IT department. Webex is a standard nowadays and the necessary installation is fast and easy.

Programme

Cross Contamination Control - Live Online Training

Seminar Programme as PDF

Regulatory Requirements: Contamination Control Strategy & Cross Contamination
  • The view of EMA
  • The view of US-FDA
  • Shared facilities regulations
  • Contamination and sterile products
Sources of Contamination – Modes of Cross Contamination – Segregation
  • Do different sources mean different impact?
  • Where cross contamination could occur and different likelihoods
  • Is segregation a no brainer?
  • Cross contamination in Biotech
Containment Solutions – Avoiding Exposure – Minimizing Cross Contamination
  • Exposure and how to calculate
  • Equipment and containment concepts
    • Closed product handling
    • Sampling
    • Material Transfer
  • The PDE/ADE concept: how much contamination is allowed?
  • Avoiding of cross contamination
    • Air born contamination
    • Contamination of surfaces
  • Verification of the tightness of a containment system
Cross Contamination through poor Organisation
  • Organisational points to consider
  • The human factor
  • The importance of training and motivation
Cross Contamination through poor HVAC Design
  • Airborne particles
  • Pressure / hygienic zones – maintaining over pressure
  • The clean corridor Concept
  • Simulation and visualisation of air flow
  • Classification of ventilation Systems
  • Concepts for HVAC Systems
  • Components of AHUs (filters, Duct work, etc...)
  • Classification and change of filters
  • Control and monitoring strategies
Cross Contamination through poor Equipment Design
  • Cleanability of equipment as the key to avoiding crosscontamination
  • In-line cleanability? – Cleanability for parts that are disassembled?
  • Importance of drainability (cross-contamination by product and detergent residues)
  • Gap-free and dead-space-free design of system components
    • Components (connections, valves, pumps, sensors)
    • Mixing and preparation vessels, bioreactors
  • Cross-contamination due to lack of technical support
    • Deterioration of surface Quality
    • Wear of static and dynamic seals
Cleaning & Cleaning Validation
  • Poor Cleaning – main reason for cross contamination
  • Dealing with multipurpose strategies in cross contamination Control
  • Cross Contamination – main focus of cleaning validation
Documentation: CCS, HBEL assessment, QRM
  • Cross contamination control and CCS
  • HBEL – from the environmental risk to patient’s risk
  • Cross contamination control – it is all about QRM

stop

This course is part of the GMP Certification Programme "ECA Certified Technical Operations Manager" Learn more

ECA-Member*: € 1890,-
Non ECA Member*: € 2090,-
EU/GMP Inspectorates*: € 1045,-
APIC Member Discount*: € 1990,-

(All prices excl. VAT). Important notes on sales tax.

* also payable by credit card
American Express Visa Mastercard

icon
Further dates on-site
Further dates on-site
Not available
icon
Further dates online
Further dates online
Not available
icon
Recording
Not available

Do you have any questions?

Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org

Woman with headset

Go back

Testimonials about our courses and conferences

"Great material and speakers" and "Great speakers a lot of experience and sharing"

Felipe Gonzalez, Mucos Emulsionsgesellschaft mbH
Live Online Training - Granulation & Tableting, September 2024

"The lectures were very informative, interesting and entertaining."

Albert Godoy Hernández, Company synaffix
Live Online Training - GMP Auditor Practice, October 2024

"Really useful training which I will use in my daily work."

Regina Mommaerts, Galapagos NV
Live Online Training - GMP Auditor Practice, October 2024

"Wonderful format of the sessions: Good range of participations and experience in the team. Would love to attend another one soon."

Roopasi Mathi, Wacker Biotech B.V.
Live Online Training - GMP Auditor Practice, October 2024

"Very good balance between general and detailed information"

Dr Ralf Albrecht, Tillotts Pharma AG
Live Online Training - Granulation & Tableting
September 2024

"Nice presentations: easy understanding, quite visual"

Susana Manrique, Boehringer Ingelheim España, S.A,
Live Online Training - Granulation & Tableting, September 2024

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023

 

“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024

 

“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024

 

 

“Well prepared presentations and good presenters. I also like the way of asking questions.”

Alexandra Weidler, Hookipa Biotech GmbH, Austria
Live Online Training – QP Education Course Module A, November 2023

 

Important note

Due to our company holidays, no registrations for recordings can be processed between 21.12.2024 and 01.01.2025.

Thank you for your understanding.

Your ECA Academy